Market Cap | 7.28M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -13.72M | Forward P/E | -23.76 | EPS next Y | - | 50D Avg Chg | 32.00% |
Sales | 8.27M | PEG | - | EPS past 5Y | - | 200D Avg Chg | 47.00% |
Dividend | N/A | Price/Book | 11.11 | EPS next 5Y | - | 52W High Chg | -58.00% |
Recommedations | 2.00 | Quick Ratio | 0.12 | Shares Outstanding | 1.41M | 52W Low Chg | 184.00% |
Insider Own | 24.06% | ROA | -55.90% | Shares Float | 527.62K | Beta | 1.93 |
Inst Own | 4.85% | ROE | -3,099.92% | Shares Shorted/Prior | 20.53K/55.98K | Price | 10.69 |
Gross Margin | 31.41% | Profit Margin | -215.71% | Avg. Volume | 659,062 | Target Price | - |
Oper. Margin | -263.25% | Earnings Date | May 13 | Volume | 8,860,731 | Change | 61.48% |
TRxADE HEALTH, Inc. operates as a health services information technology (IT) company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement; and designs, develops, owns, and operates a business-to-business web-based marketplace. It also distributes prescription medication, medical devices, and over the counter medication to pharmacies and medical clinics; and offers pricing transparency, purchasing capabilities, and other value-added services, as well as telehealth services. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. was founded in 2010 and is headquartered in Lutz, Florida.
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
AJJARAPU SURENDRA K | CEO CEO | May 20 | Buy | 13000 | 10,000 | 130,000,000 | 222,500 | 05/23/22 |